These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 27230303)

  • 21. Requirements for nitric oxide generation from isoniazid activation in vitro and inhibition of mycobacterial respiration in vivo.
    Timmins GS; Master S; Rusnak F; Deretic V
    J Bacteriol; 2004 Aug; 186(16):5427-31. PubMed ID: 15292144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thymoquinone (TQ) inhibits the replication of intracellular Mycobacterium tuberculosis in macrophages and modulates nitric oxide production.
    Mahmud HA; Seo H; Kim S; Islam MI; Nam KW; Cho HD; Song HY
    BMC Complement Altern Med; 2017 May; 17(1):279. PubMed ID: 28545436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Resistance-conferring mutations of Mycobacterium tuberculosis strains with low level resistance to isoniazid].
    Ano H; Matsumoto T; Nagai T; Tamura Y; Yoshida H; Kawahara K; Takamatsu I; Tsuyuguchi I; Takashima T
    Kekkaku; 2006 Dec; 81(12):709-13. PubMed ID: 17240915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interdependence between Interleukin-1 and Tumor Necrosis Factor Regulates TNF-Dependent Control of Mycobacterium tuberculosis Infection.
    Di Paolo NC; Shafiani S; Day T; Papayannopoulou T; Russell DW; Iwakura Y; Sherman D; Urdahl K; Shayakhmetov DM
    Immunity; 2015 Dec; 43(6):1125-36. PubMed ID: 26682985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing isogenic strains of Beijing genotype Mycobacterium tuberculosis after acquisition of Isoniazid resistance: A proteomics approach.
    Nieto R LM; Mehaffy C; Dobos KM
    Proteomics; 2016 May; 16(9):1376-80. PubMed ID: 26929115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical Characterization of Isoniazid-resistant
    Nieto R LM; Mehaffy C; Islam MN; Fitzgerald B; Belisle J; Prenni J; Dobos K
    Mol Cell Proteomics; 2018 Sep; 17(9):1685-1701. PubMed ID: 29844232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Superoxide reactivity of KatG: insights into isoniazid resistance pathways in TB.
    Ghiladi RA; Cabelli DE; Ortiz de Montellano PR
    J Am Chem Soc; 2004 Apr; 126(15):4772-3. PubMed ID: 15080669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitric oxide generated from isoniazid activation by KatG: source of nitric oxide and activity against Mycobacterium tuberculosis.
    Timmins GS; Master S; Rusnak F; Deretic V
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3006-9. PubMed ID: 15273113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isoniazid@Fe2 O3 Nanocontainers and Their Antibacterial Effect on Tuberculosis Mycobacteria.
    Leidinger P; Treptow J; Hagens K; Eich J; Zehethofer N; Schwudke D; Oehlmann W; Lünsdorf H; Goldmann O; Schaible UE; Dittmar KE; Feldmann C
    Angew Chem Int Ed Engl; 2015 Oct; 54(43):12597-601. PubMed ID: 26332072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glibenclamide alters interleukin-8 and interleukin-1β of primary human monocytes from diabetes patients against Mycobacterium tuberculosis infection.
    Kewcharoenwong C; Saenwongsa W; Willcocks SJ; Bancroft GJ; Fletcher HA; Lertmemongkolchai G
    Tuberculosis (Edinb); 2020 Jul; 123():101939. PubMed ID: 32452426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A study of INH 0.1 microgram/ml resistant M. tuberculosis strains assessed by BrothMIC MTB-1 method].
    Yoshida H; Ano H; Ishida C; Tanigawa N; Kikui M; Takashima T; Tsuyuguchi I
    Kekkaku; 2002 Jul; 77(7):533-5. PubMed ID: 12187818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isoniazid (INH) treatment of INH-resistant Mycobacterium tuberculosis inhibits infected macrophage to produce TNF-alpha.
    Wibawa T; Pangemanan L; Rachmawaty FJ; Rintiswati N; Mustofa ; Soesatyo MH
    Southeast Asian J Trop Med Public Health; 2014 Sep; 45(5):1107-13. PubMed ID: 25417512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid speciation of 15 clinically relevant mycobacteria with simultaneous detection of resistance to rifampin, isoniazid, and streptomycin in Mycobacterium tuberculosis complex.
    Shenai S; Rodrigues C; Mehta A
    Int J Infect Dis; 2009 Jan; 13(1):46-58. PubMed ID: 18565777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isoniazid resistance and the point mutation of codon 463 of katG gene of Mycobacterium tuberculosis.
    Shim TS; Yoo CG; Han SK; Shim YS; Kim YW
    J Korean Med Sci; 1997 Apr; 12(2):92-8. PubMed ID: 9170012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transferrin conjugates of antitubercular drug isoniazid: Synthesis and in vitro efficacy.
    Sutar YB; Mali JK; Telvekar VN; Rajmani RS; Singh A
    Eur J Med Chem; 2019 Dec; 183():111713. PubMed ID: 31557610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of mechanism of interaction of truncated isoniazid-nicotinamide adenine dinucleotide adduct against multiple enzymes of Mycobacterium tuberculosis by a computational approach.
    Jena L; Deshmukh S; Waghmare P; Kumar S; Harinath BC
    Int J Mycobacteriol; 2015 Dec; 4(4):276-83. PubMed ID: 26964808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The timing of TNF and IFN-gamma signaling affects macrophage activation strategies during Mycobacterium tuberculosis infection.
    Ray JC; Wang J; Chan J; Kirschner DE
    J Theor Biol; 2008 May; 252(1):24-38. PubMed ID: 18321531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycobacterium tuberculosis persistence mutants identified by screening in isoniazid-treated mice.
    Dhar N; McKinney JD
    Proc Natl Acad Sci U S A; 2010 Jul; 107(27):12275-80. PubMed ID: 20566858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection.
    Greco E; Quintiliani G; Santucci MB; Serafino A; Ciccaglione AR; Marcantonio C; Papi M; Maulucci G; Delogu G; Martino A; Goletti D; Sarmati L; Andreoni M; Altieri A; Alma M; Caccamo N; Di Liberto D; De Spirito M; Savage ND; Nisini R; Dieli F; Ottenhoff TH; Fraziano M
    Proc Natl Acad Sci U S A; 2012 May; 109(21):E1360-8. PubMed ID: 22538807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of efflux activity to isoniazid resistance in the Mycobacterium tuberculosis complex.
    Rodrigues L; Machado D; Couto I; Amaral L; Viveiros M
    Infect Genet Evol; 2012 Jun; 12(4):695-700. PubMed ID: 21871582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.